Abstract. Ezrin is a component of the microvillus cytoskeleton of a variety of polarized epithelial cells and is believed to function as a membrane-cytoskeletal linker. In this study, we isolated microvilli from human placental syncytiotrophoblast as a model system for biochemical analysis of ezrin function. In contrast to intestinal microvilli, ezrin is a major protein component of placental microvilli, comprising ~5 % of the total protein mass and present at about one quarter of the molar abundance of actin. Gel filtration and chemical cross-linking studies demonstrated that ezrin exists mainly in the form of noncovalent dimers and higher order oligomers in extracts of placental microvilli. A novel form of ezrin, apparently representing covalently cross-linked adducts, was present as a relatively minor constituent of placental microvilli. Both oligomers and adducts remained associated with the detergent-insoluble cytoskeleton, indicating a tight interaction with actin filaments. Moreover, stimulation of human A431 carcinoma cells with EGF induces the rapid formation of ezrin oligomers in vivo, thus identifying a signal transduction pathway involving ezrin oligomerization coincident with microvillus assembly. In addition to time course studies, experiments with tyrosine kinase and tyrosine phosphatase inhibitors revealed a correlation between the phosphorylation of ezrin on tyrosine and the onset of oligomer formation, consistent with the possibility that phosphorylation of ezrin might be required for the generation of stable oligomers. Based on these observations, a model for the assembly of cell surface structures is proposed.
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ZRIN was identified over twelve years ago as a minor component of the isolated intestinal microvillus cytoskeleton (Bretscher, 1983) , and has since been found in the apical microvilli of a wide variety of polarized epithelial cell types within the body (Hanzel et al., 1991; Wolf et al., 1991; Berryman et al., 1993; Hofer and Drenckhahn, 1993) , in the microvilli and other actin-rich surface structures of cultured cells (Bretscher, 1983 (Bretscher, , 1989 Gould et al., 1986; Pakkanen, 1988; Pakkanen et al., 1987 Pakkanen et al., , 1988 Sato et al., 1992; Franck et al., 1993; Soroka et al., 1993; Algrain et al., 1993; Shuster and Herman, 1995; Martin et al., 1995) , and in the marginal band of chicken erythrocytes (Winckler et al., 1994) .
Several lines of evidence indicate that ezrin attaches microfilaments to the plasma membrane. Ezrin contains an NH2-terminal domain that shares 37% sequence identity with the corresponding region of band 4.1 (Gould et al., 1989) . This domain of band 4.1 associates with integral membrane proteins of the erythrocyte plasma membrane to mediate cytoskeletal linkages (Anderson and Lovrien, 1984; Anderson and Marchesi, 1985; Pasternack et al., 1985; Leto et al., 1986; Marfatia et al., 1994) . Support for a membrane-cytoskeletal linking function for ezrin includes immunoelectron microscopy, which has revealed that ezrin is closely and specifically associated with the microvillus plasma membrane in several epithelial cell types (Berryman et al., 1993) . Moreover, Algrain et al. (1993) have shown that the COOH-and NH2-terminal halves of ezrin associate with the cytoskeleton and plasma membrane, respectively. Complexes containing ezrin and CD44, a polymorphic integral membrane protein which binds to extracellular matrix proteins, have been isolated from cultured cells by co-immunoprecipitation (Tsukita et al., 1994) . Finally, two laboratories have identified an F-actin binding site in the COOH-terminal tail of ezrin (Turunen et al., 1994; Pestonjamasp et al., 1995) , a domain which appears to be masked in the native ezrin molecule .
Radixin and moesin are two independently discovered proteins that share 75 % sequence identity with ezrin over the entire length of the coding region (Funayama et al., 1991; Lankes and Furthmayr, 1991) . Together, these pro-teins constitute the ezrin-radixin-moesin (ERM) 1 protein family (Sato et al., 1992) . Structural analysis, localization studies, and evolutionary considerations suggest related but distinct functions for ezrin, radixin, and moesin (Gould et al., 1989; Funayama et al., 1991; Sato et al., 1992; Berryman et al., 1993; Franck et al., 1993; Gary and Bretscher, 1993; Lankes et al., 1993; Amieva et al., 1994; Takeuchi et al., 1994a,b; Tsukita et al., 1994; Winckler et al., 1994; Pestonjamasp et al., 1995) . Although ERM proteins are coexpressed in many cultured cell lines (Sato et al., 1992) , their pattern of expression in the body is mainly cell-type specific (Berryman et al., 1993; Amieva et al., 1994) . Depletion of ERM proteins by antisense oligonucleotides has provided direct evidence for their role in determining cell surface morphology (Takeuchi et al., 1994a) . In addition, ERM-related molecules which appear to play a role in cell morphology have been identified in Drosophila (Ibnsouda et al., 1993; Edwards et al., 1994) and in the sea urchin Lytechinus variegatus (Bachman and McClay, 1995 ). An intriguing property of ERM family members is their ability to associate in a homotypic or heterotypic fashion both in vivo and in vitro Andreoli et al., 1994) . These interactions appear to involve exclusively complementary binding of two nonoverlapping NH2-and COOH-terminal domains, termed N-and C-ERMADs (ezrin-radixin-moesin association domain), respectively. The C-ERMAD, which encompasses the entire F-actin binding site, is masked in native ezrin in solution, suggesting that F-actin binding as well as heteroor homotypic ERM associations might be regulated through unmasking of this domain .
A correlation between the phosphorylation of ezrin and changes in cell morphology has been demonstrated in several systems. There exists a close temporal relationship between the phosphorylation of ezrin on tyrosine residues and the rapid formation of microvilli and membrane ruffles enriched in both actin and ezrin in EGF-stimulated A431 cells (Bretscher, 1989) . Ezrin also becomes phosphorylated on tyrosine in many other systems (Kamps et al., 1986; Krieg and Hunter, 1992; Hansen and Moeller, 1993; Fazioli et al., 1993; Egerton et al., 1992; Thuiller et al., 1994) . Stimulation of gastric parietal cells with agents that elevate cAMP levels induces the phosphorylation of ezrin on serine and threonine residues concomitant with the appearance of microvilli rich in ezrin Hanzel et al., 1989 Hanzel et al., , 1991 .
Although ezrin purified from intestinal microvilli (Bretscher, 1983 ) and cultured human choriocarcinoma cells (Narvanan, 1985) was originally characterized as a monomeric protein in solution, subsequent studies suggested the existence of oligomeric species as well (Pakkanen and Vaheri, 1989; Ullrich et al., 1986) . We recently reported the purification from human placenta of two stable forms of ezrin that do not readily interconvert in vitro. Chemical and physical characterization revealed that they are composed of ezrin monomers and elongated dimers (Bretscher et al., 1996) . Here we show that ezrin is a major component of isolated placental microvilli where it is cytoskele-tally associated and exists primarily in oligomeric form. We also document the rapid formation of ezrin oligomers with tyrosine phosphorylation of ezrin in EGF-stimulated A431 cells. Since these growth factor-induced biochemical events coincide with the appearance of newly formed microvilli and membrane ruffles (Bretscher, 1989) , it is possible that ezrin oligomerization plays an important role in the biogenesis of these structures and in the development of epithelial cell polarity. Based on these results, we propose a speculative model for the involvement of ERM proteins in the assembly of cell surface structures.
Materials and Methods

Materials
Ezrin was purified from human placenta (Bretscher, 1989) , obtained from consenting patients at Tompkins Community Hospital (Ithaca, NY). Affinity-purified rabbit anti-human ezrin antibodies that do not recognize moesin or radixin have been described . Mouse monoclonal anti-ezrin antibody Z036, raised against a synthetic peptide corresponding to the COOH-terminal 10 residues of human ezrin, was purchased from Zymed Laboratories, Inc. (South San Francisco, CA). Affinity-purified rabbit anti-radixin antibody, raised against a synthetic peptide corresponding to residues 502-509 of mouse radixin (Fazioli et al., 1993) , was a generous gift from Dr. Di Fiore and Dr. Wong (National Institutes of Health, Bethesda, MD).
Preparation of Microvilli
Microvilli were prepared from fresh placental tissue essentially as described by Booth et al. (1980) . All steps were performed at 4°C. The umbilical cord and membranes were removed, and the placenta was cut into 20--30 g pieces. After rinsing the pieces briefly in 0.15 M NaCI (saline) to remove excess blood, the tissue was minced and stirred in 500-600 ml saline for 1 h. The material was passed through a nylon sieve (1,000 Ixm mesh) and the filtrate was centrifuged 10,000 g for 10 min. The supernatant was then centrifuged 90,000 g for 30 min. Using a loose-fitting Dounce, this pellet was resuspended in 50 ml of 10 mM mannitol, 2 mM Tris, pH 7.1, 1 mM PMSF, and 0.5 mM benzamidine. Solid MgCI2.6H20 was added to 10 mM final concentration and the suspension was stirred for 15 min, followed by centrifugation at 5,000 g for 10 min. The supernatant was centrifuged 20,000 g for 30 min to pellet the microvilli. Microvilli were washed by gentle resuspension in saline and recentrifugation. Finally, microvilli were resuspended at 1-2 mg protein/ml in saline containing 0.02% sodium azide, and either used immediately or stored on ice.
Electron Microscopy
Freshly isolated microvilli were prepared for conventional thin section analysis by initial fixation in suspension with addition of an equal volume of 4% glutaraldehyde, 4% formaldehyde, and 2% tannic acid in PBS, pH 7.0. After centrifugation, the pellet was post-fixed with 2% osmium tetroxide, dehydrated in ethanol, and embedded in Epon. Ultrathin sections were stained with uranyl acetate and lead citrate.
For immunoelectron microscopy, intact pieces of fresh placenta tissue were processed as previously described (Berryman et al., 1993) . Isolated microvilli were fixed in suspension by addition of an equal volume of 0.5% glutaraldehyde and 2% formaldehyde in PBS, pH 7.4. Following centrifugation, the pellet was treated with 50 mM ammonium chloride, post-fixed with 1% uranyl acetate, dehydrated in ethanol, and embedded in LR Gold resin as described previously (Berryman and Rodewald, 1990) . Sections were stained with 2 Ixg/ml affinity-purified ezrin antibody, followed by 5-nm colloidal gold-labeled secondary antibodies. Specimens were examined at 60 kV in a Philips 301 electron microscope (Philips Electronic Instruments Inc., Mahawah, N J).
benzamidine. The extract was clarified by centrifugation at 100,000 g for 20 min. The insoluble pellet was resuspended to the same volume as the supernatant and aliquots of these fractions were boiled in Laemmli sample buffer under reducing conditions. Immunodepletion of ezrin was performed by incubation of 400 ixl of soluble extract with 15 ixl of ezrin antiserum that had been pre-adsorbed to 25 p.l protein A-Sepharose beads (Sigma Chemical Co., St. Louis, MO). Quantitative removal of ezrin was accomplished by two sequential incubations with the immunobeads. The immunoprecipitates were washed, eluted by boiling in Laemmli sample buffer, and then pooled.
Preparation of Cytoskeletons
Microvilli in suspension (2 mg/ml) were extracted for 15 min at room temperature by addition of an equal volume of 2% Triton X-100, 75 mM KC1, 10 mM Hepes, pH 7.4, I mM DTF, 1 mM EGTA, 2 mM PMSF, and i mM benzamidine. The extract was centrifuged 20,000 g for 15 min to pellet the cytoskeletons. The pellet was washed by gentle resuspension in buffer containing 0.1% Triton X-100 and then recentrifuged. In some experiments, washed cytoskeletons were resuspended in various extraction buffers, centrifuged, and equal volumes of the soluble and insoluble fractions analyzed on stained gels and by Western blots.
Western Blots, Blot Overlay, and Lectin Blot
Proteins were resolved by SDS-PAGE (Laemmli, 1970) , and then transferred to Immobilon polyvinylidene fluoride (PVDF) membranes (Millipore Corp., Bedford, MA) using a semi-dry electroblotter (Integrated Separation Systems, Hyde Park, MA).
Western blots were blocked with 10% nonfat dry milk, and probed directly with 0.1 ixg/ml peroxidase-conjugated anti-phosphotyrosine antibody (Transduction Laboratories, Lexington, KY), or probed with 0.1 ~Lg/ ml ezrin antibody followed by 60 ng/ml protein A-peroxidase (Sigma Chem. Co.).
Biotinylated ezrin was prepared and blot overlays were performed according to the method of Gary and Bretscher (1993) . For control blots, either the biotinyl-ezrin probe was omitted or a 10-fold excess of unlabeled purified human ezrin was mixed with the biotinyl-ezrin to compete for specific ezrin binding sites on the PVDF membrane.
For lectin blots, membranes were blocked with 3% BSA, 0.5 M NaCl, 10% Tween-20, 0.05 M Tris, pH 8.0. Blots were probed directly with 0.5 ixg/ml peroxidase-conjugated concanavalin A (Sigma Chemical Co.) in blocking buffer containing 0.3% BSA.
All blots were developed by enhanced chemiluminescence (Amersham, Arlington Heights, IL). In some experiments, the blots were stripped according to the manufacturer's instructions, and then reprobed with other reagents.
Cell Culture and EGF Treatment
A431 (human epidermoid carcinoma) cells were obtained from the American Type Culture ColLection (Rockville, MD) and cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and antibiotics. Cells were grown to near confluence in 100-mm dishes and then incubated in serum-free medium for 10 h before treatment at 37°C with 100 ng/ml EGF (Upstate Biotechnology Inc., Lake Placid, NY) for various times. Next, cells were rinsed briefly with ice-cold PBS and scraped into the appropriate extraction buffer. Following brief trituration, the extracts were clarified by centrifugation at 100,000 g for 20 min, and then subjected to gel filtration chromatography or chemical cross-linking, as described below.
In some experiments, cells were treated with the indicated concentrations of tyrphostin AG1478 (Calbiochem-Novabiochem Corp., San Diego, CA) or phenylarsine oxide (Aldrich Chem. Co., Milwaukee, WI) in dimethyl sulfoxide during the last 3 h or 30 min, respectively, of serum starvation and during stimulation with EGF. Control cells were incubated with dimethyl sulfoxide alone.
Gel Filtration Chromatography and Quantitation
Placental microvilli were extracted for 10 min on ice with 1% Triton X-100, 0.6 M KC1, 10 mM Hepes, pH 7.4, 1 mM EDTA, and protease inhibitors, and then were centrifuged 100,000 g for 20 min. The supernatant was loaded onto a Superose 6 HR 10/30 (Pharmacia Fine Chemicals, Piscataway, NJ) gel filtration column equilibrated with 10 mM Hepes, 100 mM NaC1, 1 mM EDTA, pH 7.4, at a flow rate of 0.2 ml/min; 0.5 ml fractions were collected. The column was calibrated under identical conditions with conventional gel filtration standards (Sigma Chemical Co.) as well as purified ezrin monomers and dimers (Bretscher et al., 1996) . Blue dextran was used to determine the void volume.
A431 cells were stimulated with EGF for 0, 1, and 3 min, followed by extraction in the same buffer used for placental microvilli containing phosphatase inhibitors: 200 p,M sodium orthovanadate, 30 IxM phenylarsine oxide, 50 mM sodium fluoride, 50 mM ~3-glycerophosphate. Samples were chromatographed as described above in the presence of 100 ~M sodium orthovanadate.
To quantitate the relative amounts of monomeric and oligomeric forms of ezrin in extracts of A431 cells or placental microvilli, gel filtration fractions from representative experiments were pooled and adjusted to equal final volumes. The pooled fractions were then diluted serially and analyzed by Western blotting. A similar comparison was done for the oligomet-containing fractions of extracts from A431 cells treated with and without EGF.
Chemical Cross-linking
Dithiobis-succinimidyl-propionate (DSP) (Pierce Chemical Co., Rockford, IL), a homobifunctional thiol-cleavable cross-linker, was dissolved in dimethylformamide; in all experiments the final concentration of dimethylformamide was less than 5%.
Microvillus extracts were subjected to gel filtration chromatography, and aliquots from each fraction were incubated with or without 1 mM DSP for 45 min on ice. The reactions were stopped by boiling in Laemmli sample buffer under nonreducing conditions. A431 cells were stimulated with EGF for various times, followed by extraction with 1% Triton X-100, 100 mM NaCl, 20 mM Hepes, pH 7.4, 2 mM EDTA, protease inhibitors, and phosphatase inhibitors. After centrifugation, the soluble extracts were incubated with or without 0.2 mM DSP for 45 min on ice. The reactions were either stopped as described above or were quenched by the addition of 1/20 volume of 1 M Tris, 1 M glycine, pH 6.8, and subjected to immunoprecipitation with ezrin antibody.
Purification of Ezrin from Placental MicroviUi
Microvilli (5 mg) were pelleted by centrifugation and extracted with 2% Triton X-100, 0.6 M KC1, 10 mM Hepes, pH 7.4, 2 mM EDTA, and protease inhibitors. The extract was clarified by centrifugation at 100,000 g for 20 min, diluted with 5 vol of 75 mM KH2PO4, pH 7.2, and applied to a 10 ml hydroxyapatite column (HA-Ultrogel, LKB Instruments, Inc., Gaithersburg, MD) equilibrated with 0.1 M phosphate, pH 7.2. The column was washed and eluted with a 50 ml linear gradient of 100-800 mM potassium phosphate, pH 7.2. Fractions were monitored by SDS-PAGE on 10% minigels and fractions rich in ezrin pooled and dialyzed against 20 mM NaC1, 20 mM MES, pH 6.7. The material was then applied to a Mono S FPLC column (Pharmacia Fine Chemicals) and developed with a 40 ml gradient in this buffer with 20-1,000 mM NaCl. The peak ezrin-containing fractions were pooled and dialyzed in 150 mM NaC1, 1 mM EDTA, 10 mM Tris, pH 7.4, and then made 63% in ammonium sulfate. The precipitate was collected by centrifugation at 13,000 g for 15 min and immediately dissolved in a minimal volume of 100 mM NaC1, 1 mM EDTA, 10 mM Hepes, pH 7.4. The material was filtered and run on a Superose 6 HR 10/30 column equilibrated with the same buffer. Fractions containing pure ezrin were pooled, cross-linked, and then analyzed by Coomassie blue staining, Western blotting, and mass spectroscopy.
Mass Spectroscopy
Ezrin purified from placental microvilli was cross-linked with 1 mM DSP, followed by the addition of 1/20 volume of 1 M glycine, 1 M Tris, pH 6.8 to quench the reaction. The material was dialyzed extensively against deionized water, lyophilized, and then redissolved in deionized water. The masses of the cross H-linked species were determined on a matrix-assisted laser desorption mass spectrometer (Mock et al., 1991; Wang and Chait, 1994) .
Results
Ezrin Is a Major Protein of Isolated Placental Microvilli
Human placenta is known to be a rich source of ezrin (Bretscher, 1989) that is concentrated in the microvilli of the syncytiotrophoblast (Berryman et al., 1993) . High-resolution immunoelectron microscopy reveals in appropriately cut structures (Fig. 1 A, arrows) , that ezrin is closely associated with the microvillus plasma membrane of these cells. Remarkably, ezrin is essentially absent from nonmicrovillus regions of the apical plasma membrane, indicating that in these and other polarized cells (Berryman et al., 1993) , ezrin is highly specific for actin-containing surface structures.
Given the abundance and distribution of ezrin in placental microvilli, we reasoned that these structures might be an excellent system for biochemical analysis of ezrin function. We therefore purified placental microvilli using a modification of established procedures (Booth et al., 1980) , resuiting in a preparation of microvilli that resembled their counterparts on intact cells. By thin section electron microscopy, the isolated structures appeared as right-sideout, spherical and elongated microvillus vesicles (Fig. 1 B) . Contamination with other organelles was minimal: for example, very few nuclei or mitochondria were seen. Immunoelectron microscopy revealed that >80% of the structures contained ezrin (Fig. 1 C) . In negative stain preparations of glutaraldehyde-fixed microvilli, we observed a network of fine filaments within the interior of many structures, indicating that the integrity of the cytoskeleton was at least partially preserved. Negative staining also revealed the presence of some clathrin coated vesicles, which was not surprising since placenta is a classic source for their purification (Pearse, 1982) . S D S -P A G E analysis of the overall composition of isolated microvilli (Fig. 2 A) showed a reproducible, simple polypeptide profile, in good agreement with earlier studies Ezrin is a major protein of placental microvilli. Microvilli were extracted with RIPA buffer and ultracentrifuged to give insoluble and soluble fractions. The soluble fraction was depleted of ezrin by incubation with ezrin antiserum that had been pre-adsorbed to protein A-Sepharose beads. The immunobeads were washed, and then eluted by boiling in Laemmli sample buffer. (A) Proteins from equal volumes of total microvilli, RIPA-insoluble and -soluble fractions, immunodepleted extract, and the corresponding immunoprecipitate were resolved by SDS-PAGE on 10% gels under reducing conditions and stained with Coomassie blue. The major 81-kD band in the RIPA-soluble fraction was removed quantitatively by immunoprecipitation with ezrin antibody. The volume of immunoprecipitate loaded on the gel represents 5% of the total material eluted from the immunobeads. Actin (43 kD) and a-actinin (105 kD) are seen as abundant proteins which are relatively insoluble in RIPA buffer. (B) Equal volumes of RIPA-insoluble and -soluble fractions were diluted serially (twofold), run on SDS-PAGE, transferred to PVDF membranes, and then probed with ezrin antibody and peroxidase-conjugated protein A. Similar concentrations of ezrin are seen in both fractions, indicating that ezrin accounts for most or all of the major 81-kD band seen in total microvillus proteins. (Edwards and Booth, 1987; Booth and Vanderpuye, 1983; Truman and Ford, 1986; Vanderpuye et al., 1986) . Among the most abundant polypeptide components are several members of the annexin family of proteins (Edwards and Booth, 1987) , actin, a 70-kD doublet, ezrin, and et-actinin (Vanderpuye et al., 1986) . Treatment of the microvilli with RIPA buffer, which is often used to solubilize cells for immunoprecipitation studies, extracted surprisingly little of the actin, about half of the ezrin, and little of the ct-actinin. The 81-kD band extracted by RIPA buffer was identified as ezrin because it could be removed quantitatively from the extract by immunoprecipitation with ezrin antibody (Fig. 2 A) . Since about half of the 81-kD polypeptide was extracted from these structures with RIPA buffer, we questioned whether the 81-kD polypeptide in the residual insoluble material was also ezrin. Western blot analysis of serial dilutions of SDS-solubilized RIPA-soluble and RfPAinsoluble fractions showed that both contained about the same amount of ezrin polypeptide (Fig. 2 B) . Therefore, most, if not all, of the material at 81-kD is ezrin, of which about half can be extracted with RIPA buffer. By comparison with known amounts of purified protein, we estimate that ezrin comprises ~5 % of the total protein mass of isolated microvilli. The subunit molar abundance of actin/ezrin/ a-actinin, as determined by densitometry of Coomassie blue-stained gels, was 10:2.4:1.
Western blots of total microvillus proteins probed with antibodies specific for moesin and radixin (Fazioli et al., 1993) revealed variable but minor amounts of these related proteins. This was expected for moesin since it is enriched in stromal endothelial cells and not the syncytiotrophoblast (Berryman et al., 1993) . The localization of radixin has not been reported in placenta, so the possibility that a small amount of the material in our preparations at ~81 kD is radixin cannot be excluded.
Placental Microvilli Contain Multiple Covalent Ezrin Adducts
In addition to the major 81-kD ezrin band, several polypeptides with a mobility ranging from ~180-220-kD were recognized by affinity-purified ezrin antibody in Western blots of total microvillus proteins (Fig. 3 A) . As compared with p81 ezrin, the high molecular weight species were extracted poorly by RIPA buffer, suggesting a very tight association with the cytoskeleton. We refer collectively to these novel ezrin-immunoreactive species as covalent adducts, because several criteria established that they contain the ezrin polypeptide. First, the adducts were recognized specifically by three different ezrin antibodies, including the anti-peptide monoclonal Z036. A banding pattern similar to the Western blot in Fig. 3 A is representative of the species seen in a number of different microvillus preparations. No significant qualitative or quantitative changes in this banding pattern were apparent after storage of microvilli for two weeks on ice, ten freeze-thaw cycles before or after boiling in Laemmli buffer, increasing the concentration of reducing agent, or boiling for various times (0-180 s) in Laemmli buffer. Although the individual adduct species appeared minor in abundance relative to the major 81-kD ezrin band, and were difficult to see on stained gels, collectively they represented a significant proportion of Figure 3 . Identification of covalent ezrin adducts. Proteins from the immunodepletion experiment were boiled in Laemmli sample buffer under reducing conditions, run on 8% gels (15% of the sample volumes used in Fig. 2 A) , and transferred to PVDF membranes. The blots were probed with either ezrin antibody (A) or biotinyl-ezrin (B) followed by the appropriate peroxidase-conjugated secondary reagent, and then were developed with enhanced chemiluminescence. In addition to the major 81-kD ezrin band, a series of high molecular weight bands (,-o180-220 kD) is seen in extracts of total microvilli. Although the high molecular weight bands vary in intensity between the Western blot and the blot overlay, comparison of different exposures showed that each band that stained with ezrin antibody also reacted in the blot overlay. Note that the individual adducts are minor in abundance relative to the major 81-kD ezrin band. In addition, the adducts are relatively insoluble in RIPA buffer compared with 81-kD ezrin. Longer exposures were required to reveal the presence of adducts in the immunoprecipitate (IP) and quantitative depletion of adducts from the RIPA-soluble fraction (not shown).
the total population of ezrin-immunoreactive species. Second, the small amount of adducts solubilized by RIPA buffer were precipitated by ezrin antibody (Fig. 3 A, lane 
IP*).
Third, p81 and the adduct bands were recognized directly by biotinylated ezrin in blot overlays (Fig. 3 B) . Earlier work has shown that ezrin specifically interacts with itself and other ERM family members in this assay . Although the relative staining intensity varied among individual adducts both within and between the two blotting methods we used (compare Total in Fig. 3, A and B) , analysis of Western blots and blot overlays exposed for various times revealed identical banding patterns comprised of up to twelve distinct adduct species. The specificity of the blot overlay was confirmed by inclusion of excess unlabeled purified ezrin to compete with biotinyl-ezrin binding sites on the blot, resulting in a loss of adduct staining and a decreased signal at 81 kD.
Ezrin Is a Component of the Detergent-insoluble Cytoskeleton
Extraction of microvilli with 1% Triton X-100 under physiological salt conditions to yield classic cytoskeletons showed that ~50% of the total ezrin at 81 kD was associated with the detergent-insoluble fraction (Fig. 4 B) , similar to that seen in extracts prepared with RIPA buffer (Fig. 3 A) . The adducts were even more resistant to extraction under these conditions (~80% insoluble), suggesting a tighter association with the cytoskeleton. The 81-kD ezrin and the adducts both remained completely insoluble when cytoskeletons were extracted under low salt (10 mM KC1) conditions, and only minor amounts were extracted by millimolar concentrations of divalent cations (data not shown). Extraction of cytoskeletons with 1 M KC1 solubilized ~75% of the 81-kD ezrin and a small proportion of the adducts. The adducts required extraction with 6 M urea to achieve greater than 50% solubility.
In addition to ezrin, the detergent-insoluble material was enriched in the cytoskeletal markers actin and et-actinin (Fig. 4 A) . The lectin blot in Fig. 4 C shows that the detergent-soluble fraction was highly enriched in membrane glycoproteins, demonstrating that efficient solubilization of membrane proteins was achieved under these conditions.
Ezrin Exists Primarily As Noncovalent Oligomers in Placental Microvilli
We recently described the purification and characterization of ezrin monomers and noncovalent dimers from human placenta (Bretscher et al., 1996) . To determine which species are present in placental microvilli, we analyzed high salt detergent extracts of microvilli by gel filtration Figure 4 . Ezrin is a major component of the detergent-insoluble cytoskeleton. Microvilli were extracted with Triton X-100 at a protein/detergent mass ratio of 1:10 to prepare detergent-insoluble and -soluble fractions, representing cytoskeletal and membrane fractions, respectively. After centrifugation and washing, equal volumes of the detergent-insoluble pellet (P) and detergent-soluble supernatant (S) were boiled in Laemmli buffer under reducing conditions, and then run on 8% SDS-PAGE either individually, or as a mixture to yield total proteins (T). Gels were either stained with Coomassie blue (A), or were transferred to PVDF membranes and then probed with ezrin antibody (B), or concanavalin A (C). The Western blot shows that approximately half of the 81-kD ezrin band is associated with the detergentinsoluble pellet whereas the ezrin adducts are preferentially associated with this fraction. In addition to ezrin, actin, and a-actinin are seen as major proteins of the Triton X-100-insoluble material. The lectin blot shows that the extraction conditions employed effectively solubilized the concanavalin A-binding glycoproteins of the microvillus membrane.
chromatography on a Superose 6 column previously calibrated with conventional standards as well as purified ezrin monomers (Stokes radius 41.~,) and dimers (72_A). Under these extraction conditions, ~70% of the ezrin was solubilized (Fig. 5 A, lanes P and S) . As shown in the Coomassie blue-stained gel and Western blot in Fig. 5, A and B, ezrin exhibited an unusually broad elution profile compared with other proteins, and was resolved into two peaks corresponding to the monomer (M; fractions 35-37) and the dimer (D; fractions 31-32) . A substantial amount of ezrin eluted ahead of the dimer (fractions 25-30), perhaps reflecting higher order ezrin oligomers. Evidence to support this notion is presented in Fig. 5 C. We have shown previously by SDS-PAGE that chemical cross-linking of purified ezrin monomers and dimers yields broad bands at ~81 and ~180 kD, respectively (Bretscher et al., 1996) . In Western blots of fractions subjected to chemical crosslinking with DSP, we observed several high molecular weight bands, each of which exhibited a characteristic mobility during SDS-PAGE that correlated well with its relative position of elution during chromatography. The relative mobilities of the cross-linked monomer and dimer were identical to that seen with the purified proteins (Bretscher et al., 1996) . At least two additional higher order oligomeric species were resolved both by gel filtration (fractions 25-30) and SDS-PAGE of cross-linked ezrin. The Stokes radius of the putative trimer was determined to be 85A. Quantitative analysis revealed that the oligomers (dimer and higher) account for ~70% of the total ezrin mass in the microvillus extract. These noncovalent oligomers are remarkably stable in high salt: extracts of microvillus cytoskeletons prepared and chromatographed in the presence of 2 M KC1 yielded results similar to those shown in Fig. 5 . However, all the noncovalent oligomers were completely reduced to monomers in microvillus extracts prepared and fractionated by gel filtration in the presence of 4 M urea.
To determine whether or not the ezrin-containing bands generated by cross-linking consist entirely of ezrin, we purified ezrin from placental microvilli by sequential chromatography on hydroxyapatite and Mono S cation exchange resins, ammonium sulfate fractionation, and gel filtration. The purified ezrin migrated as a single 81-kD band in Coomassie blue-stained gels (Fig. 6 A) under both reducing and nonreducing conditions. As expected, cross-linking of purified ezrin with DSP yielded two broad bands corresponding to the relative mobilities of cross-linked ezrin monomer and dimer (Fig. 6 B) . The masses of the purified cross-linked monomer and dimer, as determined by mass spectroscopy, were 71,162 and 141,789 D, respectively, consistent with the predicted molecular masses of these species after chemical modification (Gould et al., 1989; Bretscher et al., 1996) . Although at least two additional high molecular weight bands were detected with longer exposures of the blot shown in Fig. 6 B, the masses of these higher order oligomers were not determined due to insufficient quantities.
EGF Stimulates the Formation of Ezrin Oligomers In Vivo
Since placental microvilli contain abundant ezrin dimers, we reasoned that stimulation of A431 cells with EGF, Figure 5 . Identification of noncovalent ezrin oligomers by gel filtration chromatography and chemical cross-linking. Microvilli were extracted with buffer containing 1% Triton X-100, 0.6 M KCI, and protease inhibitors, followed by centrifugation to yield an insoluble pellet (P) and soluble supernatant (S). The supernatant, which contained ~70% of total ezrin, was then fractionated on a Superose 6 gel filtration column. Aliquots from fractions 18-42 were boiled in Laemmli sample buffer under reducing conditions. Proteins were resolved by SDS-PAGE on 8% gels and either stained with Coomassie blue (A), or transferred to PVDF membranes and probed with ezrin antibody (B). The broad elution profile of ezrin is unique compared with other proteins. Two peaks are seen which correspond to the dimeric (D; fractions 31-32) and monomeric (M; fractions 35-37) forms of ezrin, as determined by calibration of the column with purified ezrin dimers and monomers. Note that a-actinin, a dimer having a Stokes radius of 77A (Suzuki et al., 1976) , elutes immediately before the ezrin dimer, which has a Stokes radius of 72,~ (Bretscher et al., 1996) . The existence of higher order oligomers is suggested by the substantial amount of the ezrin seen in fractions 25-30. The column void volume emerges in fraction 18. Samples from fractions 18-42 were subjected to cross-linking with DSP, run on 6% SDS-PAGE under nonreducing conditions, transferred to PVDF membranes, and probed with ezrin antibody (C). Cross-linking caused shifts in the migration of the various ezrin species during SDS-PAGE which correspond well with their elution profile across fractions 25-37. Broad bands are seen which correspond to the monomer, dimer, and higher order ezrin oligomers. The putative trimer (*) has a Stokes radius of 85A. which induces microvillus formation, might result in an increase in the proportion of ezrin dimers in vivo. Although about half of the ezrin in A431 cells is cytoskeletally associated when they are prepared under very gentle conditions (Gould et al., 1986) , > 9 5 % of the ezrin can be extracted when cells are solubilized with T r i t o n X -1 0 0 and 0.6 M KC1 (Fig. 7 A) . High salt detergent extracts from cells treated with or without E G F were fractionated by gel filtration and analyzed by Western blotting (Fig. 7 B) . In contrast to placental microvilli, ~9 5 % of the ezrin in unstimulated A431 cell extracts was monomeric. However, about a twofold increase in the amount of ezrin migrating at the position of the dimer was seen in extracts prepared just two minutes after stimulation with E G F .
To determine the relationship between phosphorylation of ezrin on tyrosine and oligomer formation as a function of time after E G F treatment, we devised an assay in which cell extracts were subjected to chemical cross-linking with a relatively low concentration of DSP and then analyzed by Western blotting. As shown in Fig. 8 A, cross-linking resulted in the appearance of a high molecular weight ezrin species which increased in abundance within 1 min after addition of E G F ; no further increase was seen with 4 or 10 min of E G F treatment. This result is consistent with the rapid formation of ezrin dimers described in Fig. 7 B. In Fig. 8 A, the cross-linked dimer has an apparent mobility in excess of 180 kD; however, we have found that the apparent mobility of this species is sensitive to the acrylamide concentration. Although it is difficult to prove that the cross-linked species seen in Fig. 8 A actually represents ezrin dimers, they were found to migrate with a mobility characteristic of a cross-linked dimer. In the same assay, ezrin was seen as a major E G F -i n d u c e d phosphotyrosinecontaining band in blots probed with phosphotyrosine antibody (Fig. 8 B) . The identity of this 81-kD phosphotyrosine band as ezrin was confirmed by immunodepletion (data not shown) and immunoprecipitation experiments (Fig. 8 C) .
The correlation between E G F -i n d u c e d ezrin tyrosine phosphorylation and oligomerization was extended through the use of a tyrosine kinase inhibitor and a tyrosine phosphatase inhibitor (Fig. 9) . Treatment of cells with tyrphostin AG1478, a potent inhibitor of the E G F receptor kinase (Fry et al., 1994; Osherov and Levitski, 1994; W a r d et al., 1994) , before and during stimulation with E G F , blocked both tyrosine phosphorylation of ezrin and de novo forma- Figure 6 . Chemical cross-linking of ezrin purified from placental microvilli. (A) Purified microvillar ezrin was run on 10% SDS-PAGE in the presence of reducing agent, and visualized by Coomassie blue staining. Ezrin appears to be devoid of any major protein contaminants and migrates as a single band at 81 kD. (B) The sample shown in A was run on 6% SDS-PAGE in the absence of reducing agent before and after cross-linking with DSP, then transferred to a PVDF membrane and probed with ezrin antibody. The products of the cross-linking reaction consist of two broad bands at ~81 and ~180 kD, corresponding to the monomeric and dimeric forms of ezrin, respectively. As expected, a single band is seen at 81 kD in the absence of cross-linking. Equal amounts of protein were loaded for all three samples. tion of ezrin oligomers. Conversely, incubation with phenylarsine oxide, a tyrosine phosphatase inhibitor, enhanced the degree of ezrin phosphorylation and increased the amount of ezrin oligomer formed. Although the data suggest that tyrosine phosphorylation might be necessary for ezrin oligomerization, two lines of evidence show that this modification is not required for the maintenance of stable oligomers. First, the level of ezrin oligomer was essentially constant from 1-10 min of E G F treatment (Fig. 8 A) , whereas the level of phosphotyrosine-containing ezrin declined within this time frame (Fig. 8 B) . Second, no specific phosphotyrosine staining of ezrin was detected in Western blots of ezrin immunoprecipitates from placental microvilli (~5 I~g ezrin loaded onto gel) (data not shown).
Discussion
In this report we have examined the molecular structure of ezrin in microvilli isolated from the placental syncytiotrophoblast. These microvilli were previously known to contain ezrin, based on Western blotting and immunocytochemistry (Berryman et al., 1993) . The protein composition of cytoskeletons from placental microvilli is quite distinct from that of the intestinal brush border (Bretscher, 1991) , presumably reflecting differences in cytoskeletal architecture, morphology, and function between these two polarized epithelial cell types. In isolated intestinal microvilli, where ezrin is a relatively minor constituent, the actin filaments are bundled together by fimbrin and villin, and this (lanes 1-3) were analyzed on Western blots probed with ezrin antibody. Greater than 95% of the total ezrin was soluble. (B) Soluble extracts prepared from cells treated with or without EGF for 2 min were run separately on a Superose 6 column. Fractions were analyzed by Western blotting with ezrin antibody. Peak fractions representing the position of the dimer (D) and monomer (M) forms of ezrin are indicated. Although the same amount of ezrin was loaded onto the column (L) for both extracts, a significant increase in the amount of ezrin dimer is seen in extracts from EGFstimulated cells.
bundle is attached laterally to the plasma membrane by brush border myosin I (Bretscher, 1991) . In contrast, isolated placental microvilli lack fimbrin and villin, but do contain a-actinin and ezrin as two major components of their actin-based cytoskeletons. Structurally, the intestinal brush border is characterized by densely packed microvilli of uniform size and shape, which have a highly ordered microfilament core bundle that inserts into a well-structured terminal web. In contrast, the syncytiotrophoblast brush border displays less dense packing of microvilli, which vary in size and shape and are often bridged by clathrincoated pits at their bases, and whose apparently disorganized cytoskeletons are supported by a loosely organized terminal web. These ultrastructural features correlate with the relatively high rates of endocytic uptake and membrane recycling at the apical surface of the syncytiotrophoblast. Our immunoelectron microscopy studies reveal a high concentration and close association of ezrin with the microvillus plasma membrane, but little or none in coated pits or other invaginations of the apical membrane. These observations are consistent with the proposed membranecytoskeletal linking function of ezrin, and also suggest the possibility that ezrin may serve a tethering role which limits or prevents the diffusion of certain resident membrane proteins into coated pits, thereby helping to maintain cell polarity.
We have demonstrated that ezrin is highly abundant in placental microvilli, and that much of it is associated with the cytoskeleton. Extraction of placental microvilli with detergent and physiologically relevant buffers resulted in the solubilization of about half the ezrin together with Figure 8 . Time course of EGF stimulation shows a correlation between the onset of ezrin oligomer formation and the phosphorylation of ezrin on tyrosine. A431 cells were treated with EGF for various times (0, 1, 4, and 10 min) and scraped into solubilization buffer. After centrifugation to remove insoluble material, the extracts were subjected to cross-linking with DSP, and the products of the reaction resolved by 7 % SDS-PAGE under nonreducing conditions. Proteins were transferred to PVDF membranes, and probed with either ezrin antibody (A) or anti-phosphotyrosine antibody (B). As seen in A, the addition of cross-linking reagent resulted in the appearance of a high molecular weight ezrin species, which presumably represents the dimeric form resolved by gel filtration in Fig. 7 B. This band increases in intensity within 1 min after addition of EGF and shows little further increase at 4 or 10 min. In B, uncross-linked ezrin is seen as a major EGF-induced 81-kD phosphotyrosine-containing protein in cells stimulated for 1 min with EGF. The level of tyrosine phosphorylation of ezrin is maximal at 1 min and progressively decreases at 4 and 10 min after growth factor treatment. The addition of DSP resulted in a correspondingly diminished phosphotyrosine signal at each time point. Ezrin was immunoprecipitated from crosslinked extracts and analyzed on a Western blot probed with phosphotyrosine antibody (C). The time course of phosphotyrosine staining of 81-kD ezrin parallels what is seen in total extracts in B.
some of the ~t-actinin and actin. Increasing amounts of ezrin and other cytoskeletal components could be titrated from the cytoskeletons with increasing salt concentrations. Surprisingly, ~1 0 % of the ezrin, and a significant proportion of the actin, was resistant to extraction even by 2 M KC1. Gel filtration analysis of intact microvilli solubilized by 0.6 M KC1 or of cytoskeletons extracted with 2 M KC1 gave similar ezrin elution profiles with the bulk of the ezrin migrating as oligomers, while most of the actin eluted as a m o n o m e r and ~t-actinin as an homogeneous dimer. In contrast, in 4 M urea, all the ezrin eluted as a monomeric species yet the ~-actinin still remained a dimer. These observations show that much of the ezrin is very tightly associated Figure 9 . EGF-induced ezrin oligomerization is inhibited by tyrphostin AG1478 and enhanced by phenylarsine oxide. Serumstarved A431 cells were stimulated with EGF for 0 (lanes 1 and 5) or 1 rain (lanes 2-4 and lanes 6-8). Tyrphostin AG1478 was used at 2.5 txM to inhibit the EGF receptor kinase and was present in the medium for 3 h before and during treatment with EGF (lanes 3 and 7). Phenylarsine oxide was used at 30 txM to inhibit tyrosine phosphatase activity and was present for 30 rain before and during growth factor treatment (lanes 4 and 8). Cells were scraped into solubilization buffer, centrifuged, and cross-linked with DSP. The cross-linked extracts were quenched, and then either boiled in Laemmli sample buffer (lanes 1-4) or subjected to immunoprecipitation with ezrin antibody (lanes 5-8). A mock immunoprecipitate was prepared in the absence of cell extract to control for background antibody staining (lane 9). Proteins were run on 7% SDS-PAGE under nonreducing conditions, transferred to PVDF membranes, and probed with either phosphotyrosine antibody (A) or ezrin antibody (B). As shown in A, the relative amounts of phosphotyrosine staining of 81-kD ezrin in both the total crosslinked extracts (lanes 1-4) and the immunoprecipitates (lanes 5-8) corresponds well with the overall levels of phosphotyrosine staining of other proteins in the extracts, including the EGF receptor. Note that treatment of cells with PAO resulted in the appearance of a high molecular weight phosphotyrosine-containing band in the ezrin immunoprecipitate that exhibits the same mobility as the cross-linked ezrin dimer (lane 8, arrow) . In B, the bulk of the ezrin migrated at 81 kD in each of the extracts. However, the relative amounts of cross-linked dimer formed (D, arrows) correlate positively with the levels of tyrosine phosphorylation of ezrin seen in A.
with the cytoskeleton, and that the extracted material contains multiple ezrin species.
A n unanticipated finding was that the bulk of the ezrin extracted from placental microvilli exists as dimeric and higher oligomeric forms. It seems reasonable to predict that the assembly hierarchy of the oligomers is monomers to dimers, to trimers, to tetramers, etc. This prediction is based on the physical properties of purified monomers and dimers, and the existence of exclusively complemen-tary association domains in the ezrin polypeptide known as N-ERMADs and C-ERMADs (Bretscher et al., 1996; Gary and Bretscher, 1995) . The interactions that stabilize the dimer likely involve the association of the N-ERMAD of one molecule with the C-ERMAD of a second subunit. Since the C-ERMAD is masked in soluble monomeric ezrin, thereby precluding dimer formation, some regulatory step must be required to activate or otherwise expose this domain to form a dimer (Gary and Bretscher, 1996) . Because the dimer also has a masked C-ERMAD (Bretscher et al., 1996) , we hypothesize that multiple activation events are required for the formation of trimers and higher order structures. These monomers, dimers, trimers, etc. that we can extract from placental microvilli in vitro apparently represent distinct and stable ezrin populations that coexist in vivo.
In addition to these noncovalent oligomers, placental microvilli contain a minor, yet perhaps significant, population of covalently cross-linked ezrin species. A plausible explanation for their existence is that noncovalent ezrin oligomers are converted into covalent adducts by some endogenous cross-linking activity (e.g., a transglutaminase). This cross-linking presumably occurs in vivo, since the adducts did not increase in abundance after prolonged storage of isolated microvilli for up to two weeks on ice or after incubation at 37°C for 30 min, nor do they appear to be artifacts induced by sample preparation. The variable mobility of the adducts during SDS-PAGE may result from the introduction of topologically different cross-links, or the cross-linking of ezrin to some other protein. Although minor, and therefore technically difficult to work with, the adducts might be of considerable importance as they are much more tightly associated with the microvillus cytoskeleton than the rest of the ezrin.
Since the discovery of ezrin (Bretscher, 1983) , there have been a number of puzzling findings surrounding the study of this microfilament-associated protein. First, although apparently a cytoskeletal molecule, ezrin is generally very easy to extract from cultured cells and tissues (Bretscher, 1983 (Bretscher, , 1989 Narvanen, 1985; Hanzel et al., 1991) . However, our results show that ezrin behaves as a bona fide cytoskeletal protein in isolated placental microvilli, since cytoskeletally associated ezrin remained largely insoluble over a wide range of salt concentrations. Second, although the native intact molecule binds poorly to F-actin in vitro (Bretscher, 1983) , Algrain et al. (1993) have nevertheless demonstrated that the COOH-terminal half of ezrin has the capacity to interact with F-actin in vivo. Furthermore, two independent laboratories have recently shown that the COOH-terminal region of ezrin is capable of direct association with F-actin in vitro (Turunen et al., 1994; Pestonjamasp et al., 1995) . Third, purified ezrin monomers and dimers can coexist as stable independent populations and show little or no subunit exchange in vitro (Bretscher et al., 1996) . Recent results from our laboratory have provided evidence that the F-actin binding domain, which is contained within the C-ERMAD, is inaccessible in the native ezrin monomer . Thus, it appears that the intermolecular interactions which govern F-actin binding and ezrin oligomerization are both subject to regulatory controls that affect the conformation of the C-ERMAD. This notion is further supported by studies in which ectopic expression of the COOH-and NH2-terminal halves, but not full-length ERM proteins, produce distinct morphogenetic effects in transfected cells (Algrain et al., 1993; Martin et al., 1995; Henry et al., 1995) .
How can we account for all these diverse findings to explain the different structural forms of ezrin found in vivo and relate them to function? As shown in the schematic diagram in Fig. 10 , our hypothesis starts with the idea that a dormant form of monomeric ezrin exists in the cytoplasm; in many cultured cell lines this may represent the bulk of the ezrin present. In response to a signal to remodel its cortical cytoskeleton to form actin-containing surface structures, dormant ezrin becomes activated, perhaps by some localized membrane-associated activator. Two types of activation can be envisaged: unmasking of the C-ERMAD for association with the N-ERMAD of another molecule to induce oligomerization, or unmasking of the COOHterminal domain to reveal the F-actin binding site. The relationship between these two types of unmasking events remains to be determined. Once bound to F-actin, ezrin binds tenaciously, thus explaining its tight association with F-actin in placental microvilli and its ability to bind F-actin in overlay assays (Pestonjamasp et al., 1995) . In addition to F-actin binding, ezrin must be able to associate with some membrane protein, either as a result of concomitant unmasking of an appropriate site, or possibly by the enhanced avidity afforded by the multivalency of the oligomeric species. Although the membrane binding partner of placental ezrin is currently unknown, Tsukita et al. (1994) Figure 10. Speculative model for the involvement of ezrin and related molecules (ERM proteins) in the assembly of cell surface structures. It is envisaged that a pool of dormant monomeric ezrin, containing a masked F-actin binding site and a masked C-ERMAD (C), exists free in the cytoplasm. An activation step, perhaps mediated locally by some membrane-associated factor, acts on monomeric ezrin to unmask the C-ERMAD for oligomer formation through association with an N-ERMAD (N) of another molecule, or to unmask the F-actin binding site. This may require additional activation steps because purified ezrin dimers also have masked C-ERMADs and F-actin binding sites (Bretscher et al., 1996) . Evidence for stimulated oligomer formation is presented in this paper. At some stage the ezrin molecules (here depicted as trimers, but likely a mixture of various oligomeric species) associate with the membrane. Introduction of an F-actin cross-linker (such as a-actinin), will naturally drive the formation of a microvillus. In this scenario, ezrin oligomers will be found preferentially in surface structures, as reported here.
have reported the identification of the hyaluronate receptor CD44 as a membrane receptor for ERM proteins in some cells; however this does not appear to be relevant to placental microvilli because they apparently lack this protein (our unpublished observations; St. Jacques et al., 1993). Finally, additional proteins might be involved in the morphogenesis of microvilli such as the F-actin cross-linking protein depicted in Fig. 10 .
What might the ezrin activation process be? We have demonstrated that treatment of A431 cells with EGF induces a rapid (<1 min) increase in tyrosine phosphorylation of ezrin and in the formation of ezrin oligomers, suggesting that tyrosine phosphorylation and oligomerization might play a critical role in microvillus assembly. Although tyrosine phosphorylation may represent one step in a pathway leading to ezrin oligomerization or F-actin binding, our results indicate that stable oligomers can persist following a decrease in tyrosine phosphorylation. It is interesting to note that ezrin also becomes phosphorylated on tyrosine in a variety of growth factor-stimulated cells, virus-infected cells, and transformed cell lines (Bretscher, 1989 . In many of these cases, the phosphorylation of ezrin correlates with the formation of ezrincontaining surface microvilli or membrane ruffles. The notion that phosphorylation of ezrin might regulate oligomerization is now further substantiated by the fact that these two events have been shown to occur together within the same signal transduction pathway. We speculate that activation or unmasking of the C-ERMAD in ezrin monomers allows for oligomer formation, F-actin binding, and membrane association to occur either simultaneously or in rapid succession to generate microvilli. The challenge now is to determine what factors control oligomer formation and how this process is integrated into the circuitry that modulates the architecture of the cortical cytoskeleton.
